MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31.

Income Overview

Net Income
-$725K
EPS
$0.01
Unit: Thousand (K) dollars

Income Statement
2026-03-31
2025-12-31
Research and development expenses
-411*
General and administrative expenses
-455*
Intangible asset and goodwill impairment expenses
-2,420*
Operating loss
--3,286*
Financial expense (income), net
-14*
Loss before tax expenses
--3,272*
Research and development expenses
473 -
General and administrative expenses
266 -
Operating loss
-739 -
Tax expenses
-90*
Financial income, net
14 -
Net loss and comprehensive loss
-725 -3,362
Basic EPS
0.01 -0.055
Diluted EPS
0.01 -0.055
Basic Average Shares
60,729,100 60,729,100
Diluted Average Shares
60,729,100 60,729,100
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss andcomprehensive loss-$725K Financial income, net$14K Operating loss-$739K Research and developmentexpenses$473K General andadministrative expenses$266K

Revium Rx. (RVRC)

Revium Rx. (RVRC)